(Q39971657)

16 September 2017

title

Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy (English)

1 reference

16 September 2017

0 references

1 reference

Atsushi Ochiai

1

1 reference

16 September 2017

Koji Okihara

2

1 reference

16 September 2017

Kazumi Kamoi

3

1 reference

16 September 2017

Tsuyoshi Iwata

4

1 reference

16 September 2017

Akihiro Kawauchi

5

1 reference

16 September 2017

Tsuneharu Miki

6

1 reference

16 September 2017

Zephyr Fors

7

1 reference

16 September 2017

publication date

1 March 2011

1 reference

International Journal of Urology

16 September 2017

published in

1 reference

16 September 2017

volume

18

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

200-205

1 reference

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

PCA3: a molecular urine assay for predicting prostate biopsy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02711.X

10.1111/J.1442-2042.2010.02711.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference